Latest news

Image of the month - November

11 / 17 / 2022

Image of the month - November

Check out – It’s our ‘UNSHAVED’ image for Movember!
Beyond the mustache, we at Explicyte are calling for awareness to ‘change the face’ of men’s health - mental health issues and especially cancers.
Let’s dig together into and mobilize around male cancer research!

Meet Explicyte! Join us at The 37th annual SITC event in Boston

10 / 20 / 2022

Meet Explicyte! Join us at  The 37th annual SITC event in Boston

We very much look forward to attending the @Society for Immunotherapy of Cancer Annual Meeting in Boston from November 8 to 12, and to showcasing our recent research works through our posters. Plan to stop by to talk of them and about your research programs.

Interested in meeting us to learn on our services offerings and how they can support your needs? Reach us for scheduling!

Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist

09 / 12 / 2022

Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist

Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study
Journal of Hematology & Oncology, 2022, October 27

Mariella Spalato‑Ceruso, Fanny Bouteiller, Jean‑Philippe Guegan, Maud Toulmonde, Alban Bessede, Michèle Kind, Sophie Cousin, Xavier Buy, Jean Palussiere, François Le Loarer, Berengere Dadone‑Montaudie, Marina Pulido and Antoine Italiano

NEW IN VIVO SHUTTLE CAMPAIGN!

09 / 08 / 2022

NEW IN VIVO SHUTTLE CAMPAIGN!

Save the date for our new in vivo shuttle campaign!

We are committed to providing world-class supports to advance your preclinical projects and immunotherapy drug discovery using syngeneic tumor mouse models through our comprehensive in vivo Immuno-Oncology platform.

Sign up! It’s for early November

Image of the month - July

07 / 12 / 2022

Image of the month - July

Check out - it's our favorite image of the month

What a pretty multiplexed image showing the tumor microenvironment (TME) on a human NSCLC section, highlighting PDL1 positive tumor cells surrounded by macrophages and T cells.